glp 1 agonist and depression Reassuring' findings suggest GLP-1 receptor agonists do not increase suicide risk GLP-1 receptor agonists attenuate depressive

GLP-1 receptor agonist drugs (e.g., semaglutide, liraglutide, tirzapeptide) work by mimicking natural GLP-1 but last much longer

Allulose can be used in beverages, baking, or as a tabletop sweetener, though its properties differ slightly from sucrose in cooking applications

Abbreviations: GLP-1RAs: glucagon-like peptide-1 receptor agonists

Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss

While liraglutide improved spatial cognition, it also reduced astrocytes and microglia activity, ameliorated amount of A levels and mitochondrial dysfunction in cortical and hippocampal CA1 and CA3 regions, and prevented neuron loss by activating cAMP/PKA pathway in brain of 5FAD mice (188, 208)

Patients usually need to try other treatments first